Pharmaceuticals in Emerging Markets: The Next Growth Stories

Pharmaceutical companies are increasingly evaluating second tier emerging markets. By 2022, emerging markets will account for nearly 50% of the global pharmaceutical market, up from 35% currently. In addition to rising incomes and greater political stability, the key drivers of expansion are ageing populations, Westernisation of diets and more government investment in healthcare. This week’s podcast features Jamie Davies, who is BMI’s Head of Pharmaceuticals, Medical Devices and Healthcare.